Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics segment, providing pathology and radiology services across multiple locations in India. The company offers diagnostic testing through walk-in centres, home sample collection services, and digital reporting systems. Its service portfolio caters to both individual patients and institutional clients, including hospitals, clinics, and other healthcare establishments, covering routine diagnostics as well as specialised testing requirements.
Applicants who wish to participate in the Modern Diagnostic & Research Centre Limited IPO can apply through an authorised trading platform or by using the ASBA facility provided by their banking institution. The application process generally involves logging into the trading or banking application, navigating to the IPO section, selecting the Modern Diagnostic & Research Centre Limited IPO, and entering the required lot quantity within the specified price band. Applicants must authorise the payment mandate through UPI or bank authentication before the cut-off time on the issue closing date. After submission, the application proceeds through exchange-regulated verification and allotment procedures, which determine the final allocation status.
For more details, visit the Modern Diagnostic & Research Centre Limited IPO page.
Modern Diagnostic & Research Centre Limited IPO Details and Objectives
Details
| Information
|
IPO Date
| December 31, 2025 to January 2, 2026
|
Issue Size
| 40,99,200 shares (agg. up to ₹37 Cr)
|
Price Band
| ₹85 to ₹90 per share
|
Lot Size
| 1600 shares
|
Listing At
| BSE, SME
|
Market Maker
| Spread X Securities Pvt. Ltd.
|
Purpose of the IPO
Funding capital expenditure for purchase of medical equipment towards establishment of new diagnostic centre and labs
Funding Working Capital Requirement
Repayment of certain outstanding borrowings availed by the Company
General Corporate Purpose
Timeline of Modern Diagnostic & Research Centre Limited IPO
Event
| Date
|
|---|
IPO Open Date
| Wed, Dec 31, 2025
|
IPO Close Date
| Fri, Jan 2, 2026
|
Tentative Allotment
| Mon, Jan 5, 2026
|
Initiation of Refunds
| Tue, Jan 6, 2026
|
Credit of Shares to Demat
| Tue, Jan 6, 2026
|
Tentative Listing Date
| Wed, Jan 7, 2026
|
Pricing & Lot Size of Modern Diagnostic & Research Centre Limited IPO
Price Band for the IPO
Minimum Lot Size and Application Details
Application
| Lots
| Shares
| Amount
|
Individual investors (Retail) (Min)
| 2
| 3,200
| ₹2,88,000
|
Individual investors (Retail) (Max)
| 2
| 3,200
| ₹2,88,000
|
S-HNI (Min)
| 3
| 4,800
| ₹4,32,000
|
S-HNI (Max)
| 6
| 9,600
| ₹8,64,000
|
B-HNI (Min)
| 7
| 11,200
| ₹10,08,000
|
Modern Diagnostic & Research Centre Limited IPO Application Process
The Modern Diagnostic & Research Centre Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Modern Diagnostic & Research Centre Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (lot size: 1600 shares) within the price band of ₹85 to ₹90 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Shares Offered in Modern Diagnostic & Research Centre Limited IPO
The Modern Diagnostic & Research Centre Limited IPO includes a structured allocation of equity shares across investor categories such as anchor investors, qualified institutional buyers, non-institutional investors, and retail investors. The distribution below outlines the share allocation and relative proportion assigned to each category as part of the overall public issue.
Category
| Shares Offered
| Amount (Rs Cr)
| Size (%)
|
Market Maker
| 2,06,000
| 1.86
| 5.04%
|
QIB
| 19,44,800
| 17.50
| 47.42%
|
- Anchor Investor
| 11,61,600
| 10.45
| 28.34%
|
- QIB (Ex Anchor)
| 7,82,400
| 7.04
| 19.09%
|
NII
| 5,85,600
| 5.27
| 14.29%
|
- bNII (bids above ₹10L)
| 3,90,200
| 3.51
| 9.52%
|
- sNII (bids below ₹10L)
| 1,95,200
| 1.76
| 4.76%
|
Retail
| 13,63,200
| 12.27
| 33.26%
|
Total
| 40,99,200
| 36.89
| 100%
|
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹49.49 crore in FY24 to ₹77.86 crore as of June 2025.
Total income: Reached ₹22.67 crore in FY25, as compared to ₹68.67 crore in FY24.
Profit After Tax (PAT): Stood at ₹3.00 crore for June 2025 as compared to ₹5.79 crore in FY24.
Net Worth: Recorded at ₹23.72 crore in FY25 in comparison to ₹11.76 crore in FY24.
Reserves and surplus: Stood at ₹12.72 crore in FY25, as compared to ₹10.76 crore in FY24.
EBITDA: Stood at ₹5.86 crore in June 2025 in comparison to ₹11.05 crore in FY24.
Recent Performance and Growth Prospects
Modern Diagnostic & Research Centre Limited has reported an increase in its total asset base in the latest reporting period, indicating continued investment in infrastructure, equipment, and operational capabilities to support its diagnostic services network.
Variations in total income between reporting periods reflect changes in testing volumes, service mix, and timing of revenue recognition, which are typical in diagnostic operations influenced by patient demand and institutional business cycles.
The latest reported period shows a change in profit after tax and EBITDA compared to the previous financial year, highlighting shifts in operating margins, cost structures, and utilisation levels across diagnostic centres.
Growth in net worth and reserves suggests retention of earnings within the business, contributing to a strengthening of the company’s capital base despite fluctuations in income and profitability.
The company’s recent financial performance reflects characteristics common to healthcare diagnostics providers, where outcomes may vary across periods due to changes in demand patterns, service expansion, and operational scale.
Future growth prospects are linked to the company’s ability to expand its diagnostic service offerings, maintain service quality, and manage operational efficiency across pathology and radiology segments.
Ongoing demand for diagnostic testing, preventive health check-ups, and institutional healthcare services may continue to influence performance, alongside the company’s approach to capacity utilisation, cost management, and geographic presence.
Investment Risks and Opportunities
Potential Risks of Investing in the IPO
Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics segment, where testing volumes and revenue can fluctuate based on patient demand, referral patterns, and overall healthcare utilisation trends.
The company’s operations depend on the effective management of diagnostic centres, and factors such as equipment maintenance, staffing requirements, and regulatory compliance may affect service continuity and operating performance.
Opportunities and Growth Potential
Ongoing demand for diagnostic testing, preventive health check-ups, and specialised pathology and radiology services may support continued utilisation of the company’s diagnostic network.
The company’s presence across multiple locations and its mix of walk-in services, home sample collection, and institutional business provide opportunities to serve a broad range of diagnostic requirements across different customer segments.
Key Performance Indicator (KPI)
KPI
| Values
|
ROE
| 55.21%
|
ROCE
| 36.18%
|
Debt/Equity
| 1.07
|
RoNW
| 43.27%
|
PAT Margin
| 11.51%
|
EBITDA Margin
| 23.04%
|
Price to Book Value
| 4.78
|
Modern Diagnostic & Research Centre Limited IPO Registrar & Lead Managers
Registrar
| Lead Manager(s)
|
|---|
MUFG Intime India Pvt. Ltd.
| Beeline Capital Advisors Pvt. Ltd.
|
Company Address of Modern Diagnostic & Research Centre Limited
Modern Diagnostic & Research Centre Ltd. Address Plot No H-64,1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi West Delhi, New Delhi, 110015
Phone: 9999474297
Email: compliance@mdrcindia.com
Website: http://www.mdrcindia.com/
Conclusion
Modern Diagnostic & Research Centre Limited operates in the healthcare diagnostics space, offering pathology and radiology services through a network of diagnostic centres and laboratories. Its operations span direct patient services and institutional engagements, supported by infrastructure investments, equipment upgrades, and service expansion initiatives. The IPO outlines objectives related to funding capital expenditure, meeting working capital requirements, repayment of certain borrowings, and general corporate purposes, along with clearly defined issue timelines and pricing details.
Applications for the Modern Diagnostic & Research Centre Limited IPO can be submitted through authorised trading platforms or via the ASBA facility offered by banking institutions. The application process involves selecting the IPO, entering the applicable lot quantity, authorising the payment mandate through UPI or bank authentication, and completing the submission within the prescribed timeframe. The application then moves through exchange-regulated verification and allotment procedures, which determine the final allocation outcome.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Modern Diagnostic & Research Centre IPO allotment status.